Suppr超能文献

[与肿瘤内异质性相关的食管癌中hst-1基因扩增强度及恶性潜能]

[The intensity of hst-1 gene amplification and malignant potential of esophageal carcinoma in relation to intratumoral heterogeneity].

作者信息

Chikuba K, Saito T, Kaketani K, Uchino S, Sato K, Shimoda K, Miyahara M, Kobayashi M

机构信息

First Dept. of Surgery, Oita Medical University.

出版信息

Gan To Kagaku Ryoho. 1993 Apr;20(6):763-6.

PMID:8489282
Abstract

Amplification of hst-1 gene is associated with poor prognosis in patients with esophageal carcinoma. Since there is a high frequency of DNA stem-line heterogeneity, we studied intratumoral heterogeneity of hst-1 amplification, and evaluated whether or not the intensity of hst-1 amplification is associated with the malignant potential of esophageal carcinoma. A total of 73 patients with esophageal carcinoma who had undergone esophagectomy were studied. Intratumoral heterogeneity of hst-1 amplification was examined in two to four sections of tumour specimens which showed mainly DNA heterogeneity in 27 of these patients. The judgement of hst-1 amplification in the same tumor was identical in all of the 27 patients, although its intensity was not identical in some cases. And in 73 patients, postoperative recurrence in organs showed a high incidence (78%) in the hst-1 amplification group with a high intensity (over 7-fold). Therefore, hst-1 amplification exceeding 7-fold can serve as an indicator to predict the high grade of malignant potential of esophageal carcinoma.

摘要

hst-1基因扩增与食管癌患者的不良预后相关。由于DNA干细胞系异质性频率较高,我们研究了hst-1扩增的肿瘤内异质性,并评估hst-1扩增强度是否与食管癌的恶性潜能相关。共研究了73例接受食管切除术的食管癌患者。在27例主要表现为DNA异质性的肿瘤标本的两到四个切片中检查hst-1扩增的肿瘤内异质性。在所有27例患者中,同一肿瘤中hst-1扩增的判断是一致的,尽管在某些情况下其强度并不相同。在73例患者中,hst-1高强度扩增组(超过7倍)的器官术后复发率较高(78%)。因此,hst-1扩增超过7倍可作为预测食管癌高恶性潜能的指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验